140 related articles for article (PubMed ID: 10933337)
1. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
Greenwald MK; Stitzer ML
Drug Alcohol Depend; 1998 Dec; 53(1):17-30. PubMed ID: 10933337
[TBL] [Abstract][Full Text] [Related]
2. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
[TBL] [Abstract][Full Text] [Related]
4. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
Walsh SL; Chausmer AE; Strain EC; Bigelow GE
Psychopharmacology (Berl); 2008 Jan; 196(1):143-55. PubMed ID: 17909753
[TBL] [Abstract][Full Text] [Related]
6. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
Wongchanapai W; Tsang BK; He Z; Ho IK
Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
Tokuyama S; Feng Y; Wakabayashi H; Ho IK
Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
[TBL] [Abstract][Full Text] [Related]
8. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
[TBL] [Abstract][Full Text] [Related]
9. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
10. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor.
Smith MA; Picker MJ
Psychopharmacology (Berl); 1998 Nov; 140(1):57-68. PubMed ID: 9862403
[TBL] [Abstract][Full Text] [Related]
12. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
[TBL] [Abstract][Full Text] [Related]
13. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
Walsh SL; Strain EC; Abreu ME; Bigelow GE
Psychopharmacology (Berl); 2001 Sep; 157(2):151-62. PubMed ID: 11594439
[TBL] [Abstract][Full Text] [Related]
14. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
[TBL] [Abstract][Full Text] [Related]
15. Opioid antagonists and butorphanol dependence.
Jaw SP; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1993 Mar; 44(3):497-500. PubMed ID: 8383850
[TBL] [Abstract][Full Text] [Related]
16. STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE.
Grechko OY; Shtareva DM; Spasov AA; Litvinov LA; Rashchenko AI
Eksp Klin Farmakol; 2016 Aug; 79(4):8-11. PubMed ID: 29949697
[TBL] [Abstract][Full Text] [Related]
17. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Feng Y; Rockhold RW; Ho IK
J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
[TBL] [Abstract][Full Text] [Related]
18. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Tokuyama S; Ho IK
Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
[TBL] [Abstract][Full Text] [Related]
19. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
Schlaepfer TE; Strain EC; Greenberg BD; Preston KL; Lancaster E; Bigelow GE; Barta PE; Pearlson GD
Am J Psychiatry; 1998 Apr; 155(4):470-3. PubMed ID: 9545990
[TBL] [Abstract][Full Text] [Related]
20. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
